comparemela.com

Latest Breaking News On - Mountaineer study - Page 1 : comparemela.com

HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With Tucatinib

A panel of oncologists shares comprehensive insight to clinical trial data with tucatinib in patients with HER2+ metastatic colorectal cancer.

Evolving testingTreatment strategiesMetastatic colorectal cancerClinical trial data with tucatinibColorectal cancerHer2 positiveHer2 crcHer2 targetedHer2 therapyHer2 amplificationMountaineer trialMountaineer studyMountaineer 03Combination therapyAsco 2023Asco annual meeting novel therapy

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

Micheal Foote, MD, discusses the use of tucatinib plus trastuzumab compared with chemotherapy in the management of HER2-amplified metastatic colorectal cancer.

Michael footeMemorial sloan kettering cancer centerMetastatic colorectal cancerHer2 amplifiedMetastatic colorectal cancerMountaineer study

vimarsana © 2020. All Rights Reserved.